Blog Posts

Strategy RPGs Updates, News and Data 2021-2028

Posted by costadin on June 19, 2021 at 8:36pm 0 Comments

Since the COVID-19 virus outbreak in December 2019, the disease has spread to all countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020 and 2021.

This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption,…


Simple Techniques to Learn Arabic by the Web

Posted by al-dirassa on June 19, 2021 at 8:35pm 0 Comments

How would you think about thought on learning Arabic letters in examining Arabic? Perhaps you don't assume it's so essential, for your thought process is that even the nearby Arabic people every so often don't comprehend their letters. Yet, you should bear in considerations: individuals who can't secure such letters have a place with the substantially less learned or ignorant people. Honestly the accomplished individuals can indeed process their letters which…


Stress Test Equipment Updates, News and Data 2021-2028

Posted by costadin on June 19, 2021 at 8:32pm 0 Comments

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:

ALSO READ :… Continue

Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago.

Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

The USD 3.6 billion (by 2030) financial opportunity within the Target Protein Degradation Market has been analyzed across the following segments:

Type of payment of licensing agreements
• Upfront payments
• Milestone payments

Type of protein degrader
• Degronimids
• Specific BET and DUB inhibitors
• Other protein degraders

Therapeutic area
• Neurodegenerative disorders
• Oncological disorders
• Other therapeutic areas

Route of administration
• Oral
• Intravenous
• Other routes

Key geographical region
• North America
• Europe
• Asia-Pacific

The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:

Get detailed Analysis:
Key Players
• Arvinas
• Captor Therapeutics
• Celgene
• Genetech
• Kymera Therapeutics
• Mission Therapeutics
• Progenra
• Radius Health
• Sanofi Genzyme
• Zenopharm

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Current Market Landscape
5. Company Profiles
6. Clinical Trial Analysis
7. KOL Analysis
8. Publication Analysis
9. Funding and Investment Analysis
10. Partnerships and Collaborations
11. Market Sizing and Opportunity Analysis
12. Executive Insights
13. Concluding Remarks
14. Appendix 1: Tabulated Data
15. Appendix 2: List of Companies and Organizations

Get Customized Report:

Views: 3


You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2021   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service